Castle Biosciences (CSTL) Change in Receivables (2018 - 2026)
Castle Biosciences' Change in Receivables history spans 8 years, with the latest figure at -$6.3 million for Q4 2025.
- On a quarterly basis, Change in Receivables fell 915.6% to -$6.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.9 million, a 154.39% decrease, with the full-year FY2025 number at -$6.9 million, down 154.39% from a year prior.
- Change in Receivables hit -$6.3 million in Q4 2025 for Castle Biosciences, down from -$1.9 million in the prior quarter.
- Over the last five years, Change in Receivables for CSTL hit a ceiling of $5.8 million in Q3 2023 and a floor of -$6.3 million in Q4 2025.
- Historically, Change in Receivables has averaged $1.6 million across 5 years, with a median of $2.1 million in 2021.
- Biggest five-year swings in Change in Receivables: surged 11502.0% in 2023 and later crashed 915.6% in 2025.
- Tracing CSTL's Change in Receivables over 5 years: stood at -$1.5 million in 2021, then surged by 137.09% to $540000.0 in 2022, then soared by 113.15% to $1.2 million in 2023, then crashed by 33.19% to $769000.0 in 2024, then crashed by 915.6% to -$6.3 million in 2025.
- Business Quant data shows Change in Receivables for CSTL at -$6.3 million in Q4 2025, -$1.9 million in Q3 2025, and -$3.9 million in Q2 2025.